New endowed scholarship honors academic excellence and is largest gift in Sloan Program history

Reginald M. Ballantyne III, MBA ’67 is a prominent health care industry leader and longtime supporter of Cornell programs. He has endowed a scholarship that is the largest gift in the history of the Sloan Program in Health Administration in the Cornell Jeb E. Brooks School of Public Policy.  

Around Cornell

Cornell startups get $3M from NYS to impede disease outbreak

Halomine and Inso Biosciences – both from Cornell incubators – have received $3 million in New York state grants to help thwart disease outbreaks and expand the state’s life science industries.

Cross-campus initiative to accelerate innovations in engineering, medicine

Weill Cornell Medicine and Cornell Engineering are launching an initiative, led by Emmanuel Giannelis, to form cross-disciplinary partnerships.

Herrero to bolster global dietary report with food system modeling

Mario Herrero, a professor in the Department of Global Development and a Cornell Atkinson Scholar, has been appointed to the EAT-Lancet 2.0 leadership team to spearhead the modeling workstream.

Around Cornell

Startup Cornell podcast guest works to make healthcare more accessible

The 14th episode of a podcast hosted by Entrepreneurship at Cornell, Startup Cornell, features David Stein MBA ‘20, co-founder and CEO of Ash Wellness.

Around Cornell

Study sheds light on precancerous ‘clonal outgrowth’ in blood cells

The blood stem cell mutation, known as DNMT3A R882leads to the growth of a large population of circulating blood cells that also contain this mutation.

Entrepreneurship faculty win grants for course development

The awards allow faculty affiliated with Entrepreneurship at Cornell to extend their capacity to work with students.

Around Cornell

Intestinal fortitude: Gut coils hold secrets of organ formation

A new study reveals how vertebrate guts form, with implications for how other organs develop.

Discovery illuminates how Parkinson’s disease spreads in the brain

Aggregates of a protein spread in the brains of people with Parkinson’s disease through a cellular waste-ejection process, suggests a new study led by Weill Cornell Medicine researchers.